Cargando…
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry
The development of left ventricular systolic dysfunction (LVSD) in hypertrophic cardiomyopathy (HCM) is rare but serious and associated with poor outcomes in adults. Little is known about the prevalence, predictors, and prognosis of LVSD in patients diagnosed with HCM as children. METHODS: Data from...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373850/ https://www.ncbi.nlm.nih.gov/pubmed/37226762 http://dx.doi.org/10.1161/CIRCULATIONAHA.122.062517 |
_version_ | 1785078648778260480 |
---|---|
author | Abou Alaiwi, Sarah Roston, Thomas M. Marstrand, Peter Claggett, Brian Lee Parikh, Victoria N. Helms, Adam S. Ingles, Jodie Lampert, Rachel Lakdawala, Neal K. Michels, Michelle Owens, Anjali T. Rossano, Joseph W. Saberi, Sara Abrams, Dominic J. Ashley, Euan A. Semsarian, Christopher Stendahl, John C. Ware, James S. Miller, Erin Ryan, Thomas D. Russell, Mark W. Day, Sharlene M. Olivotto, Iacopo Vissing, Christoffer R. Ho, Carolyn Y. |
author_facet | Abou Alaiwi, Sarah Roston, Thomas M. Marstrand, Peter Claggett, Brian Lee Parikh, Victoria N. Helms, Adam S. Ingles, Jodie Lampert, Rachel Lakdawala, Neal K. Michels, Michelle Owens, Anjali T. Rossano, Joseph W. Saberi, Sara Abrams, Dominic J. Ashley, Euan A. Semsarian, Christopher Stendahl, John C. Ware, James S. Miller, Erin Ryan, Thomas D. Russell, Mark W. Day, Sharlene M. Olivotto, Iacopo Vissing, Christoffer R. Ho, Carolyn Y. |
author_sort | Abou Alaiwi, Sarah |
collection | PubMed |
description | The development of left ventricular systolic dysfunction (LVSD) in hypertrophic cardiomyopathy (HCM) is rare but serious and associated with poor outcomes in adults. Little is known about the prevalence, predictors, and prognosis of LVSD in patients diagnosed with HCM as children. METHODS: Data from patients with HCM in the international, multicenter SHaRe (Sarcomeric Human Cardiomyopathy Registry) were analyzed. LVSD was defined as left ventricular ejection fraction <50% on echocardiographic reports. Prognosis was assessed by a composite of death, cardiac transplantation, and left ventricular assist device implantation. Predictors of developing incident LVSD and subsequent prognosis with LVSD were assessed using Cox proportional hazards models. RESULTS: We studied 1010 patients diagnosed with HCM during childhood (<18 years of age) and compared them with 6741 patients with HCM diagnosed as adults. In the pediatric HCM cohort, median age at HCM diagnosis was 12.7 years (interquartile range, 8.0–15.3), and 393 (36%) patients were female. At initial SHaRe site evaluation, 56 (5.5%) patients with childhood-diagnosed HCM had prevalent LVSD, and 92 (9.1%) developed incident LVSD during a median follow-up of 5.5 years. Overall LVSD prevalence was 14.7% compared with 8.7% in patients with adult-diagnosed HCM. Median age at incident LVSD was 32.6 years (interquartile range, 21.3–41.6) for the pediatric cohort and 57.2 years (interquartile range, 47.3–66.5) for the adult cohort. Predictors of developing incident LVSD in childhood-diagnosed HCM included age <12 years at HCM diagnosis (hazard ratio [HR], 1.72 [CI, 1.13–2.62), male sex (HR, 3.1 [CI, 1.88–5.2), carrying a pathogenic sarcomere variant (HR, 2.19 [CI, 1.08–4.4]), previous septal reduction therapy (HR, 2.34 [CI, 1.42–3.9]), and lower initial left ventricular ejection fraction (HR, 1.53 [CI, 1.38–1.69] per 5% decrease). Forty percent of patients with LVSD and HCM diagnosed during childhood met the composite outcome, with higher rates in female participants (HR, 2.60 [CI, 1.41–4.78]) and patients with a left ventricular ejection fraction <35% (HR, 3.76 [2.16–6.52]). CONCLUSIONS: Patients with childhood-diagnosed HCM have a significantly higher lifetime risk of developing LVSD, and LVSD emerges earlier than for patients with adult-diagnosed HCM. Regardless of age at diagnosis with HCM or LVSD, the prognosis with LVSD is poor, warranting careful surveillance for LVSD, especially as children with HCM transition to adult care. |
format | Online Article Text |
id | pubmed-10373850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-103738502023-07-28 Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry Abou Alaiwi, Sarah Roston, Thomas M. Marstrand, Peter Claggett, Brian Lee Parikh, Victoria N. Helms, Adam S. Ingles, Jodie Lampert, Rachel Lakdawala, Neal K. Michels, Michelle Owens, Anjali T. Rossano, Joseph W. Saberi, Sara Abrams, Dominic J. Ashley, Euan A. Semsarian, Christopher Stendahl, John C. Ware, James S. Miller, Erin Ryan, Thomas D. Russell, Mark W. Day, Sharlene M. Olivotto, Iacopo Vissing, Christoffer R. Ho, Carolyn Y. Circulation Original Research Articles The development of left ventricular systolic dysfunction (LVSD) in hypertrophic cardiomyopathy (HCM) is rare but serious and associated with poor outcomes in adults. Little is known about the prevalence, predictors, and prognosis of LVSD in patients diagnosed with HCM as children. METHODS: Data from patients with HCM in the international, multicenter SHaRe (Sarcomeric Human Cardiomyopathy Registry) were analyzed. LVSD was defined as left ventricular ejection fraction <50% on echocardiographic reports. Prognosis was assessed by a composite of death, cardiac transplantation, and left ventricular assist device implantation. Predictors of developing incident LVSD and subsequent prognosis with LVSD were assessed using Cox proportional hazards models. RESULTS: We studied 1010 patients diagnosed with HCM during childhood (<18 years of age) and compared them with 6741 patients with HCM diagnosed as adults. In the pediatric HCM cohort, median age at HCM diagnosis was 12.7 years (interquartile range, 8.0–15.3), and 393 (36%) patients were female. At initial SHaRe site evaluation, 56 (5.5%) patients with childhood-diagnosed HCM had prevalent LVSD, and 92 (9.1%) developed incident LVSD during a median follow-up of 5.5 years. Overall LVSD prevalence was 14.7% compared with 8.7% in patients with adult-diagnosed HCM. Median age at incident LVSD was 32.6 years (interquartile range, 21.3–41.6) for the pediatric cohort and 57.2 years (interquartile range, 47.3–66.5) for the adult cohort. Predictors of developing incident LVSD in childhood-diagnosed HCM included age <12 years at HCM diagnosis (hazard ratio [HR], 1.72 [CI, 1.13–2.62), male sex (HR, 3.1 [CI, 1.88–5.2), carrying a pathogenic sarcomere variant (HR, 2.19 [CI, 1.08–4.4]), previous septal reduction therapy (HR, 2.34 [CI, 1.42–3.9]), and lower initial left ventricular ejection fraction (HR, 1.53 [CI, 1.38–1.69] per 5% decrease). Forty percent of patients with LVSD and HCM diagnosed during childhood met the composite outcome, with higher rates in female participants (HR, 2.60 [CI, 1.41–4.78]) and patients with a left ventricular ejection fraction <35% (HR, 3.76 [2.16–6.52]). CONCLUSIONS: Patients with childhood-diagnosed HCM have a significantly higher lifetime risk of developing LVSD, and LVSD emerges earlier than for patients with adult-diagnosed HCM. Regardless of age at diagnosis with HCM or LVSD, the prognosis with LVSD is poor, warranting careful surveillance for LVSD, especially as children with HCM transition to adult care. Lippincott Williams & Wilkins 2023-05-25 2023-08-01 /pmc/articles/PMC10373850/ /pubmed/37226762 http://dx.doi.org/10.1161/CIRCULATIONAHA.122.062517 Text en © 2023 The Authors. https://creativecommons.org/licenses/by/4.0/Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
spellingShingle | Original Research Articles Abou Alaiwi, Sarah Roston, Thomas M. Marstrand, Peter Claggett, Brian Lee Parikh, Victoria N. Helms, Adam S. Ingles, Jodie Lampert, Rachel Lakdawala, Neal K. Michels, Michelle Owens, Anjali T. Rossano, Joseph W. Saberi, Sara Abrams, Dominic J. Ashley, Euan A. Semsarian, Christopher Stendahl, John C. Ware, James S. Miller, Erin Ryan, Thomas D. Russell, Mark W. Day, Sharlene M. Olivotto, Iacopo Vissing, Christoffer R. Ho, Carolyn Y. Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry |
title | Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry |
title_full | Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry |
title_fullStr | Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry |
title_full_unstemmed | Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry |
title_short | Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry |
title_sort | left ventricular systolic dysfunction in patients diagnosed with hypertrophic cardiomyopathy during childhood: insights from the share registry |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373850/ https://www.ncbi.nlm.nih.gov/pubmed/37226762 http://dx.doi.org/10.1161/CIRCULATIONAHA.122.062517 |
work_keys_str_mv | AT aboualaiwisarah leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT rostonthomasm leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT marstrandpeter leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT claggettbrianlee leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT parikhvictorian leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT helmsadams leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT inglesjodie leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT lampertrachel leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT lakdawalanealk leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT michelsmichelle leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT owensanjalit leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT rossanojosephw leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT saberisara leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT abramsdominicj leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT ashleyeuana leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT semsarianchristopher leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT stendahljohnc leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT warejamess leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT millererin leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT ryanthomasd leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT russellmarkw leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT daysharlenem leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT olivottoiacopo leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT vissingchristofferr leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry AT hocarolyny leftventricularsystolicdysfunctioninpatientsdiagnosedwithhypertrophiccardiomyopathyduringchildhoodinsightsfromtheshareregistry |